Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

A comparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer.

Rakovitch E, Franssen E, Kim J, Ackerman I, Pignol JP, Paszat L, Pritchard KI, Ho C, Redelmeier DA.

Breast Cancer Res Treat. 2003 Feb;77(3):285-93.

PMID:
12602928
2.

Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer.

Lauzier S, Maunsell E, Levesque P, Mondor M, Robert J, Robidoux A, Provencher L.

Breast Cancer Res Treat. 2010 Apr;120(3):685-91. doi: 10.1007/s10549-009-0477-z. Epub 2009 Aug 4.

PMID:
19653097
3.

A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ.

van Gestel YR, Voogd AC, Vingerhoets AJ, Mols F, Nieuwenhuijzen GA, van Driel OJ, van Berlo CL, van de Poll-Franse LV.

Eur J Cancer. 2007 Feb;43(3):549-56. Epub 2006 Nov 30.

PMID:
17140788
4.

Psychosocial distress affecting patients with ductal carcinoma in situ compared to patients with early invasive breast cancer.

Sanders JB, Loftin A, Seda JS, Ehlenbeck C.

Clin J Oncol Nurs. 2014 Dec;18(6):684-8. doi: 10.1188/14.CJON.684-688.

PMID:
25427702
5.

Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer.

Liu Y, Pérez M, Schootman M, Aft RL, Gillanders WE, Jeffe DB.

Breast Cancer Res Treat. 2011 Nov;130(1):165-73. doi: 10.1007/s10549-011-1551-x. Epub 2011 May 8.

6.

Perceptions of contralateral breast cancer: an overestimation of risk.

Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T.

Ann Surg Oncol. 2011 Oct;18(11):3129-36. doi: 10.1245/s10434-011-1914-x. Epub 2011 Sep 27.

PMID:
21947590
7.

Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.

Dzierzanowski M, Melville KA, Barnes PJ, MacIntosh RF, Caines JS, Porter GA.

J Surg Oncol. 2005 May 1;90(2):71-6.

PMID:
15844190
8.

Quality of life over time in women diagnosed with ductal carcinoma in situ, early-stage invasive breast cancer, and age-matched controls.

Jeffe DB, Pérez M, Liu Y, Collins KK, Aft RL, Schootman M.

Breast Cancer Res Treat. 2012 Jul;134(1):379-91. doi: 10.1007/s10549-012-2048-y. Epub 2012 Apr 8.

9.

Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.

Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E.

J Natl Cancer Inst. 2008 Feb 20;100(4):243-51. doi: 10.1093/jnci/djn010. Epub 2008 Feb 12.

PMID:
18270338
10.

Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.

Mirza NQ, Vlastos G, Meric F, Sahin AA, Singletary SE, Newman LA, Kuerer HM, Ames FC, Ross MI, Feig BW, Pollock RE, Buchholz TA, McNeese MD, Strom EA, Hortobagyi GN, Hunt KK.

Ann Surg Oncol. 2000 Oct;7(9):656-64.

PMID:
11034242
11.

Is there a low-grade precursor pathway in breast cancer?

King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M.

Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21.

PMID:
21935747
12.
13.

Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.

Han K, Nofech-Mozes S, Narod S, Hanna W, Vesprini D, Saskin R, Taylor C, Kong I, Paszat L, Rakovitch E.

Clin Oncol (R Coll Radiol). 2012 Apr;24(3):183-9. doi: 10.1016/j.clon.2011.09.008. Epub 2011 Sep 29.

PMID:
21958729
14.

Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.

Innos K, Horn-Ross PL.

Breast Cancer Res Treat. 2008 Oct;111(3):531-40. Epub 2007 Nov 4.

PMID:
17978879
15.
16.

Gene amplification in ductal carcinoma in situ of the breast.

Burkhardt L, Grob TJ, Hermann I, Burandt E, Choschzick M, Jänicke F, Müller V, Bokemeyer C, Simon R, Sauter G, Wilczak W, Lebeau A.

Breast Cancer Res Treat. 2010 Oct;123(3):757-65. doi: 10.1007/s10549-009-0675-8. Epub 2009 Dec 22.

PMID:
20033484
18.

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.

Mazouni C, Peintinger F, Wan-Kau S, Andre F, Gonzalez-Angulo AM, Symmans WF, Meric-Bernstam F, Valero V, Hortobagyi GN, Pusztai L.

J Clin Oncol. 2007 Jul 1;25(19):2650-5.

PMID:
17602071
19.

The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.

Fowble B, Hanlon AL, Patchefsky A, Freedman G, Hoffman JP, Sigurdson ER, Goldstein LJ.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):105-15.

PMID:
9747827
20.

Understanding a ductal carcinoma in situ diagnosis: patient views and surgeon descriptions.

Davey C, White V, Warne C, Kitchen P, Villanueva E, Erbas B.

Eur J Cancer Care (Engl). 2011 Nov;20(6):776-84. doi: 10.1111/j.1365-2354.2011.01265.x. Epub 2011 Jul 19.

PMID:
21771131

Supplemental Content

Support Center